Kairos Pharma, LTD.
For the period ended Dec 31, 2025. Filed Mar 31, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 31, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 14. Principal Accountant Fees and Services
Fees Paid to Auditors
The following table represents fees for professional audit services for the audit of the Company’s annual financial statements for the fiscal years ended December 31, 2025 and 2024, rendered by Weinberg and Company, P.A., the Company’s current independent registered public accounting firm, and Marcum LLP, the Company’s prior independent registered public accounting firm.
| Weinberg and Company, P.A. · Marcum LLP | ||||
|---|---|---|---|---|
| (in thousands) | Fiscal year ended December 31, | Fiscal year ended December 31 | ||
| 2025 | 2024 | 2025 | 2024 | |
| Audit fees 1 | $50,150 | - | $10,000 | 144,200 |
| Audit-related fees 2 | - | - | 16,000 | 59,740 |
| Tax fees | - | - | - | - |
| All other fees | - | - | - | - |
| Total fees | $50,150 | - | 26,000 | 203,940 |
| (1) | Audit fees consist of fees for the audit of the Company’s annual financial statements for 2024 and 2025 and services in connection with registration statements filed in 2024 and 2025. Audit fees also include fees related to the reviews of interim financial information included in Forms 10-Q and for consent or comfort letter procedures performed in conjunction with registration statements or completing financial transactions during the respective fiscal years. |
Audit Committee Pre-approval Policies
Our policy has been for the Audit Committee to pre-approve all audit, audit-related and non-audit services performed by our independent auditors and to subsequently review the actual fees and expenses paid to our independent auditors. Accordingly, the Audit Committee pre-approved all audit, audit-related and non-audit services performed by our independent auditors and subsequently reviewed the actual fees and expenses paid to our former auditor, Marcum LLP, during fiscal 2023 and 2024 and the actual fees and expenses paid to our current auditor, Weinberg and Company, P.A. during fiscal year 2025.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.